"Chemical entity normalization for successful translational development of ..."

Sarah Mullin et al. (2024)

> Home

Details and statistics

DOI: 10.1186/S13326-024-00314-1

access: open

type: Journal Article

metadata version: 2024-08-05

- view
  - electronic edition via DOI (open access)
  authority control:
- export record
  dblp key:
  - journals/biomedsem/MullinMCKBZ24
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/biomedsem/MullinMCKBZ24
Sarah Mullin, Robert A. McDougal, Kei-Hoi Cheung, Halil Kilicoglu, Amanda Beck, Caroline J. Zeiss:
Chemical entity normalization for successful translational development of Alzheimer's disease and dementia therapeutics. J. Biomed. Semant. 15(1): 13 (2024)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.